ArticleOncoimmunology

A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission.

Jennifer L Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.